Fmr LLC Igm Biosciences, Inc. Transaction History

Fmr LLC

$1.52 Trillion
Q2 2024

A detailed history of Fmr LLC transactions in Igm Biosciences, Inc. stock. As of the latest transaction made, Fmr LLC holds 818,873 shares of IGMS stock, worth $13.6 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

818,873

Previous 1,317,341 37.84%

Holding current value

$13.6 Million

Previous $12.7 Million 55.75%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$6.51 - $11.47 $3.25 Million - $5.72 Million	-498,468 Reduced 37.84%	818,873 $5.63 Million
Q1 2024 May 13, 2024	SELL	$8.68 - $17.36 $3.31 Million - $6.62 Million	-381,165 Reduced 22.44%	1,317,341 $12.7 Million
Q4 2023 Feb 13, 2024	SELL	$3.94 - $8.79 $1.73 Million - $3.85 Million	-438,466 Reduced 20.52%	1,698,506 $14.1 Million
Q3 2023 Nov 13, 2023	BUY	$6.66 - $10.64 $12,340 - $19,715	1,853 Added 0.09%	2,136,972 $17.8 Million
Q2 2023 Aug 11, 2023	BUY	$8.86 - $14.0 $11.4 Million - $18.1 Million	1,289,528 Added 152.5%	2,135,119 $19.7 Million
Q1 2023 May 11, 2023	BUY	$13.74 - $25.76 $2.12 Million - $3.98 Million	154,633 Added 22.38%	845,591 $11.6 Million
Q4 2022 Feb 13, 2023	BUY	$15.45 - $26.02 $10.7 Million - $18 Million	690,429 Added 130515.88%	690,958 $11.8 Million
Q3 2022 Nov 10, 2022	BUY	$15.42 - $27.01 $3,423 - $5,996	222 Added 72.31%	529 $12,000
Q2 2022 Aug 12, 2022	BUY	$13.27 - $25.5 $676 - $1,300	51 Added 19.92%	307 $5,000
Q1 2022 May 13, 2022	BUY	$13.42 - $29.73 $3,435 - $7,610	256 New	256 $7,000
Q4 2021 Feb 14, 2022	SELL	$27.59 - $66.39 $2.47 Million - $5.93 Million	-89,368 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$65.76 - $90.65 $657,600 - $906,500	-10,000 Reduced 10.06%	89,368 $5.88 Million
Q2 2021 Aug 13, 2021	BUY	$57.98 - $96.6 $5.76 Million - $9.6 Million	99,368 New	99,368 $8.27 Million

Others Institutions Holding IGMS

# of Institutions

Shares Held

21.4M

Call Options Held

39.5K

Put Options Held

16.5K

View Full List

About IGM Biosciences, Inc.

Ticker IGMS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,969,000
Market Cap $482M
Description
IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non...

More about IGMS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.

Account